Compare · AJAX vs CELG~
AJAX vs CELG~
Side-by-side comparison of Ajax I (AJAX) and Celgene Corporation (CELG~): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AJAX and CELG~ operate in n/a (n/a), so they compete in similar markets.
- AJAX carries a market cap of $753.1M.
AJAX
Ajax I
Ajax I does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Ajax I was founded in 2020 and is based in New York, New York.
Latest AJAX
- SEC Form 25-NSE filed by Ajax I
- Cazoo to Begin Trading on NYSE Today Under the Symbol "CZOO"
- SEC Form SC 13G/A filed by Ajax I (Amendment)
- Ajax I filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events
- AJAX I Shareholders Approve Proposed Business Combination with Cazoo
- SEC Form 8-K filed by Ajax I
- SEC Form SC 13G filed by Ajax I
- SEC Form 10-Q filed by Ajax I
- Ajax I filed SEC Form 8-K: Other Events
- SEC Form DEFA14A filed by Ajax I
Latest CELG~
- FDA Approval for REBLOZYL issued to CELGENE CORP
- FDA Approval for REBLOZYL issued to CELGENE CORP
- FDA Approval for REBLOZYL issued to CELGENE CORP
- FDA Approval for IDHIFA issued to CELGENE CORP
- March 27, 2021 - FDA Approves First Cell-Based Gene Therapy for Adult Patients with Multiple Myeloma
- Sutro Biopharma Announces Appointment of Jon M. Wigginton, M.D., to Board of Directors
- Sutro Biopharma to Host a Virtual KOL Event to Provide Clinical Update on Antibody-Drug Conjugate STRO-002 in Ovarian Cancer
- Global Stem Cells Market is estimated to account for US$ 18,289.9 Mn by end of 2027, Says Coherent Market Insights (CMI)